117 related articles for article (PubMed ID: 6837507)
1. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):45-8. PubMed ID: 6837506
[TBL] [Abstract][Full Text] [Related]
3. Phase II clinical evaluation of AZQ in colorectal cancer.
Bedikian AY; Stroehlein JR; Karlin DA; Korinek J; Bodey GP
Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
[TBL] [Abstract][Full Text] [Related]
5. PCNU: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
[TBL] [Abstract][Full Text] [Related]
6. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
Valdivieso M; Stroehlein JR; Bedikian AY; Karlin DA; Legha SS; Bennetts RW; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of PCNU in colorectal carcinoma.
Mitchell EP; Killen JY; Smith FP; Willis LL; Schein PS; Woolley PV
Cancer Treat Rep; 1981; 65(11-12):1129-30. PubMed ID: 7296558
[No Abstract] [Full Text] [Related]
8. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey G
Am J Clin Oncol; 1983 Apr; 6(2):187-90. PubMed ID: 6572470
[TBL] [Abstract][Full Text] [Related]
9. The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.
Drewinko B; Yang LY
Invest New Drugs; 1983; 1(3):197-202. PubMed ID: 6678867
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
Chapman RA; Natale RB; Young CW; Wittes RE
Am J Clin Oncol; 1984 Oct; 7(5):413-4. PubMed ID: 6095639
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
Feun LG; Stewart DJ; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Bodey GP
J Neurooncol; 1983; 1(1):45-8. PubMed ID: 6678305
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
Levin VA; Liu J; Weinkam RJ
Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
Lynch G; Currie V; Kemeny N
Cancer Clin Trials; 1981; 4(3):281-3. PubMed ID: 6974612
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
Woolley PV; Luc PV; Rahman A; Korsmeyer SJ; Smith FP; Schein PS
Cancer Res; 1981 Oct; 41(10):3896-900. PubMed ID: 7284999
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
[TBL] [Abstract][Full Text] [Related]
17. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
18. PCNU: a new nitrosourea in clinical oncology.
Poster DS; Penta JS; Bruno S
Am J Clin Oncol; 1982 Feb; 5(1):9-12. PubMed ID: 7081143
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of anguidine (NSC-141537) for adenocarcinoma of the colon or rectum.
Diggs CH; Scoltock MJ; Wiernik PH
Cancer Clin Trials; 1978; 1(4):297-9. PubMed ID: 757146
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
